On the other hand, CD36 deficiency promotes metabolic disorders, dyslipidemia (increasing triglyceride, fatty acid, apoB48, and chylomicron remnants in plasma levels) and sub-clinical inflammation, all of which are cardiometabolic risk factors29. This evidence concerns the gene CD36 and Other metabolic disease.